All In MedTech

Device Trial Radar · NCT05599308

Evaluation of Blood Pressure Monitor With AFib Screening Feature

Last checked: Nov 19, 2026Latest source record: Apr 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

574

Actual

Start

Sep 6, 2022

Primary completion

Apr 11, 2023

Study completion Apr 11, 2023

Sponsor

Lead sponsor
Omron Healthcare Co., Ltd.Not on our public-company list
Sponsor type
Industry
Collaborators
ICON plc
First posted
Oct 31, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Screening
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study aims to evaluate the safety and effectiveness of the Omron blood pressure (BP) monitor with AFib screening feature. The primary outcome is to validate if the Omron BP-monitor with AFib screening feature meets acceptance criteria in sensitivity and specificity. The acceptance criteria of the sensitivity and specificity should be statistically non-inferior to those of primary predicate device.

Conditions

  • Atrial Fibrillation

Interventions

  • OMRON blood pressure monitor with AFib screening featureDevice

    Blood pressure measurement by an oscillometric blood pressure monitor

  • Microlife WatchBP Home ADevice

    Blood pressure measurement by an oscillometric blood pressure monitor

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. SensitivityTime frame: 1 day
  2. SpecificityTime frame: 1 day

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Accelacare of DuPage Medical Group

    Winfield, Illinois

  • Accelacare of MacFarland Clinic

    Ames, Iowa

  • Accelacare of Charlotte

    Charlotte, North Carolina

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.